Crinetics Pharmaceuticals Inc (CRNX)
44.41
-0.96
(-2.12%)
USD |
NASDAQ |
May 31, 16:00
44.45
+0.04
(+0.09%)
After-Hours: 20:00
Crinetics Pharmaceuticals Price to Book Value: 4.003 for May 31, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 4.003 |
| May 30, 2024 | 4.089 |
| May 29, 2024 | 4.129 |
| May 28, 2024 | 4.224 |
| May 24, 2024 | 4.279 |
| May 23, 2024 | 4.383 |
| May 22, 2024 | 4.555 |
| May 21, 2024 | 4.462 |
| May 20, 2024 | 4.562 |
| May 17, 2024 | 4.633 |
| May 16, 2024 | 4.679 |
| May 15, 2024 | 4.551 |
| May 14, 2024 | 4.451 |
| May 13, 2024 | 4.32 |
| May 10, 2024 | 4.326 |
| May 09, 2024 | 4.454 |
| May 08, 2024 | 4.587 |
| May 07, 2024 | 4.296 |
| May 06, 2024 | 4.191 |
| May 03, 2024 | 4.248 |
| May 02, 2024 | 4.210 |
| May 01, 2024 | 4.054 |
| April 30, 2024 | 3.944 |
| April 29, 2024 | 3.96 |
| April 26, 2024 | 3.791 |
| Date | Value |
|---|---|
| April 25, 2024 | 3.806 |
| April 24, 2024 | 3.899 |
| April 23, 2024 | 3.980 |
| April 22, 2024 | 3.910 |
| April 19, 2024 | 3.867 |
| April 18, 2024 | 3.871 |
| April 17, 2024 | 3.961 |
| April 16, 2024 | 3.914 |
| April 15, 2024 | 3.931 |
| April 12, 2024 | 4.003 |
| April 11, 2024 | 4.311 |
| April 10, 2024 | 4.120 |
| April 09, 2024 | 4.211 |
| April 08, 2024 | 4.169 |
| April 05, 2024 | 4.267 |
| April 04, 2024 | 4.188 |
| April 03, 2024 | 4.275 |
| April 02, 2024 | 4.129 |
| April 01, 2024 | 4.177 |
| March 31, 2024 | |
| March 28, 2024 | 6.766 |
| March 27, 2024 | 6.422 |
| March 26, 2024 | 6.269 |
| March 25, 2024 | 6.233 |
| March 22, 2024 | 6.402 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.124
Minimum
Oct 30 2020
7.739
Maximum
Sep 29 2023
3.736
Average
3.534
Median
Apr 01 2021
Price to Book Value Benchmarks
| Catalyst Pharmaceuticals Inc | 3.403 |
| Geron Corp | 6.106 |
| Madrigal Pharmaceuticals Inc | 5.919 |
| PTC Therapeutics Inc | -- |
| Syndax Pharmaceuticals Inc | 3.329 |
Price to Book Value Related Metrics
| PEG Ratio | -0.7707 |
| Price | 44.41 |
| Earnings Yield | -8.51% |
| Market Cap | 3.502B |
| PEGY Ratio | -0.7707 |